While straightforward economics may dictate that a pharmaceutical company’s bottom line is really driven by the need to sell its products for monetary gain, a more holistic view should be taken. The company is in a critical position, market wise in relation to government regulators and the end consumer. This dynamic environment is sometimes difficult to understand and pharmaceutical consultants can definitely benefit the company as it struggles to remain competitive.
Pharmaceutical companies must conform to strict FDA regulations, best use practices and study scientific benchmarks to provide products and services for ongoing use. The importance of marketing in this environment should never be underestimated. As the advisor to the consumer, a pharmacist or physician has a lot of input and must satisfy the patient, whilst also adhering to budgetary restrictions, insurance company stipulations and positions.
If the patient is to be adequately catered to, it is important that lines of communication between pharmaceutical companies and professionals are open and clear and this is where marketing is so important. It follows that the standard of this marketing and its effectiveness directly contributes to the patient’s ability to live a longer, healthier and more productive life. It’s crucial to remember that these forms of marketing represent a two way street. The company must not only communicate the benefits and risks of its product to the professional, the reasoning and science behind its introduction and instructions for its use, but the professional must give real world feedback and crucial data to the company.
The contribution of pharma consulting should never be underestimated as it can help to emphasise how certain conditions can be treated by emerging products and help to reveal how other illnesses, previously under-served, could be addressed. We still have many conditions without a cure and pharmaceutical company research can often go a long way to bridging that gap, if not even enabling cutting-edge treatment for patients. There is no guarantee that such amazing products may even find their way into the hands of the sufferer. Marketing plays a critical role in disseminating the information from one end of the chain to the other, into the hands of the professionals for communication with the patient.
As more and more information is revealed through scientific study, product creation and government rubber-stamping, more of a spotlight is turned on the need for treatment of chronic diseases. As such, any by-products or side effects of new solutions may not become known, nor the link between cure and original illness exposed, unless strong marketing channels are open between all concerned.
Generally, pharmaceutical consulting firms are highly skilled at developing communication between vital parties and educating all players. Their interaction, encouragement and foresight can help to ensure that the marketing machine is primed and key players are aware of each other’s vital contributions, so important in this hyper-competitive environment.
Alan Gillies is the CEO of L2L Consulting, a cutting-edge pharma consultancy firm which specialises in optimising productivity and performance within international companies by applying tailored organisational strategies.